Literature DB >> 12168319

Brain edema after intracerebral hemorrhage: the effects of systemic complement depletion.

G Xi1, Y Hua, R F Keep, J G Younger, J T Hoff.   

Abstract

The complement cascade is activated after experimental intracerebral hemorrhage (ICH) and may play an important, role in edema formation. This study investigated the effects of systemic complement depletion on brain edema formation following ICH. Thirty-six pentobarbital-anesthetized Sprague-Dawley rats were used. Treatment animals were complement-depleted with cobra venom factor (CVF) while controls received an equal volume of saline injection (i.p.). In both treatment and control rats, autologous blood (100-microL) was infused stereotactically into the right basal ganglia. Rats were sacrificed one and three days later for brain water and ion content measurements and immunohistochemical studies. Immunohistochemistry was used to detect complement C3d, C5a, and C9. Western blot analysis was applied for C9 semiquantitation. Perihematomal brain edema was reduced by systemic complement depletion at one and three days. The water content of the cerebellum (a tissue distant from the hematoma site) was unaffected by complement depletion. Immunocytochemistry found complement depletion significantly reduced perihematomal C9 deposition, C3d production, and C5a positive cell accumulation. In conclusion, complement depletion by CVF attenuates brain edema in ICH perhaps by inhibiting the inflammatory response and membrane attack complex (MAC) formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168319     DOI: 10.1007/978-3-7091-6738-0_66

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  22 in total

Review 1.  Neuroprotection against surgically induced brain injury.

Authors:  Vikram Jadhav; Ihsan Solaroglu; Andre Obenaus; John H Zhang
Journal:  Surg Neurol       Date:  2007-01

2.  Brain tissue oxygen monitoring in intracerebral hemorrhage.

Authors:  J Claude Hemphill; Diane Morabito; Mary Farrant; Geoffrey T Manley
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

4.  Dual effects of melatonin on oxidative stress after surgical brain injury in rats.

Authors:  Steve Lee; Vikram Jadhav; Robert E Ayer; Hugo Rojas; Amy Hyong; Tim Lekic; Jiping Tang; John H Zhang
Journal:  J Pineal Res       Date:  2008-06-18       Impact factor: 13.007

5.  Protective effect 3,4-dihydroxyphenylethanol in subarachnoid hemorrhage provoked oxidative neuropathy.

Authors:  Yu-Wen Zhong; Juan Wu; Hua-Long Hu; Wei-Xin Li; Yong Zhong
Journal:  Exp Ther Med       Date:  2016-07-14       Impact factor: 2.447

6.  Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.

Authors:  Z Sheng; M Prorok; F J Castellino
Journal:  Neuroscience       Date:  2010-08-03       Impact factor: 3.590

7.  Anti-adrenergic medications and edema development after intracerebral hemorrhage.

Authors:  L H Sansing; S R Messe; B L Cucchiara; P D Lyden; S E Kasner
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

8.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

9.  HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model.

Authors:  Wanqiu Chen; Vikram Jadhav; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2008-06-14       Impact factor: 5.996

10.  Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats.

Authors:  Yan Zhan; Chunhua Chen; Hidenori Suzuki; Qin Hu; Xinggang Zhi; John H Zhang
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.